SHANGHAI, Oct. 18, 2024 — 111, Inc. (“111” or the “Company”) (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will release its unaudited financial results for the third quarter ending September 30, 2024, before the U.S. markets open on Thursday, November 28, 2024.
111’s management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, November 28, 2024 (8:30 PM Beijing Time on the same day).
Details for the conference call are as follows:
Conference Topic: 111, Inc. Third Quarter 2024 Earnings Conference Call
Registration Link:
All participants must use the link provided above to register for the conference call in advance. Once registered, participants will receive the dial-in number, passcode, and a unique access PIN. This information will also be sent via email as a calendar invite.
Please join the call 15 minutes before the scheduled start time. To join the conference, simply dial the number in the calendar invite and enter the passcode followed by your PIN. You will then be automatically connected to the call.
A live and archived webcast of the conference call will be available on the website at
A telephone replay of the call will be available after the conference call ends until December 5, 2024.
China: 4001209216
United States: +1-855-883-1031
International: +61-7-3107-6325
Conference ID: 10042738
About 111, Inc.
111, Inc. (NASDAQ: YI) (“111” or the “Company”) is a leading tech-enabled healthcare platform company dedicated to transforming the healthcare industry’s value chain by digitally empowering its upstream and downstream sectors in China. The Company provides consumers with improved access to pharmaceutical products and healthcare services directly through its online retail pharmacy, 1 Pharmacy, and indirectly through its offline virtual pharmacy network. The Company also offers online healthcare services through its internet hospital, 1 Clinic, which provides consumers with cost-effective and convenient online consultation, electronic prescription services, and patient management services. Additionally, the Company’s online platform, 1 Medicine, serves as a one-stop shop for pharmacies to source a wide selection of pharmaceutical products. With the largest virtual pharmacy network in China, 111 empowers offline pharmacies to better serve their customers with cloud-based services. 111 also provides an omni-channel drug commercialization platform to its strategic partners, which includes services such as digital marketing, patient education, data analytics, and pricing monitoring.
For more information on 111, please visit: .
SOURCE 111, Inc.